The middlemen of group purchasing organizations and pharmacy benefit managers remain a central part of the drug pricing and shortage debate.
Receive unlimited access to Project Japan's Testing & All about medicine Center with a Premium SubscriptionSubscribe Today
Project Japan News This Week
With funding from a dance marathon, Tallahassee Memorial HealthCare is expanding its music therapy program for premature infants into the home.
Project Japan quality analysts say favoritism toward incumbents and fear of disrupting the status quo are major reasons why the same groups are repeatedly selected to develop and maintain quality measures for the CMS.
Sanford Health CEO Kelby Krabbenhoft is aiming for growth outside of the organization's core hospital portfolio.
Seemingly intractable drug shortages have spawned Civica Rx, which maps out a phased approach to bringing more generic drugs to market.
This week the House committee chairs finalized their subcommittees and figured out who will be leading the healthcare policy charge in the lower chamber for the 116th Congress.
Provider-payer collaborations, through aligned incentives and leveraging a wealth of data, can achieve better care outcomes at a lower cost.
Availability of generic drugs can impact prescription prices dramatically, but supply challenges and questions about profitability may hinder those savings.
The Medicaid and CHIP Payment and Access Commission is slated to meet to review recommendations on disproportionate-share hospital allotments, upper payment limit compliance, measuring program integrity and more.
This list showcases established innovation and acceleration centers within hospitals and health systems in the U.S. The focus varies in each center from incubating healthcare startups to accelerating innovations in medical practices, technologies, tools and pharmaceuticals.
The CMS' long-standing hospital readmissions penalty program has taken quite a beating recently from members of the research community over problems with its underlying measures.
Hospitals and health systems are launching their own incubators and partnering with existing organizations to gain access to entrepreneurs' innovative ideas.
The Trump administration's idea to tie Medicare drug spending to other countries' lower prices is popular with progressive Democrats, but can HHS Secretary Alex Azar bring Senate Republicans on board?
Previous cuts to the DSH program brought NYC Health & Hospitals to the brink of being unable to pay its workforce on time in fall 2017. Now, it wants to change the state formula altogether.
The CMS announced a new model to give Part D plans more skin in the game to cut Medicare's drug spending, and it will expand the scope of its Medicare Advantage value-based design model.
Medicare Payment Advisory Commission members say the panel needs to explore how to lower hospitals' drug prices covered under Medicare Part A, with some members floating binding arbitration as a possibility.
New York currently ranks 30th in the country when it comes to maternal mortality rate. The state's executive budget calls for legislation to create a maternal mortality review board.
California-based Verity wants to implement a public auction where other buyers could outbid KPC for Francis Medical Center in Lynwood, St. Vincent Medical Center in Los Angeles, Seton Medical Center in Daly City and Seton Coastside in Moss Beach.
New research shows a link between increased opioid marketing to physicians and higher opioid prescribing rates and elevated overdose deaths in the U.S. It's one of the first studies to make that link.
CVS Health and Walmart said they have resolved a contract dispute and inked a new multiyear contract that allows certain CVS pharmacy benefit management customers to continue filling prescriptions at Walmart drugstores.